Article
Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Mutation research - 7 Mar 2005
Chacko Priya, Joseph Thomas, Mathew Beela Sarah, Rajan Balakrishnan, Pillai M Radhakrishna
Abstract excerpt
Metabolic activation and inactivation of potential genotoxic agents occur by Phase I and Phase II enzymes in multiple interactions. An expanding body of literature demonstrates that ethnic differences in breast cancer incidence may be partly caused by host genetic factors particularly genetic pol...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
